A recent study has highlighted the severe emotional and social challenges faced by people living with vitiligo, a skin condition marked by loss of pigmentation and white patches.
Beyond its physical symptoms, vitiligo exacts a heavy psychological toll, with many patients experiencing depression, social isolation, and even suicidal thoughts.
The study, conducted among 430 government employees with vitiligo in Maharashtra, found that all participants felt embarrassed by their appearance.
More than half, 54.7%, avoided social gatherings altogether. Additionally, 87% reported anxiety or negative reactions from their in-laws, underscoring the stigma associated with the condition.
Published in the Annals of Plastic and Reconstructive Surgery, the research used validated psychometric tools to assess patients’ mental health and quality of life. It revealed that 60.5% of participants felt depressed, while 43.3% had considered suicide.
Every respondent said vitiligo affected their ability to form friendships and express affection. Work and study were also impacted for 71.9% of those surveyed.
Dr. Rinky Kapoor, co-founder of The Esthetic Clinics and lead author of the study, stressed the human side behind the numbers: “Each percentage point represents a real person losing confidence, relationships, and sometimes even their will to live.” She emphasized that the condition’s visibility—not its medical severity—is what causes the greatest harm.
Stigma was a significant theme, with 81.2% saying discrimination heavily affected their daily lives. Nearly 89% encountered misconceptions that vitiligo is contagious by touch. Women faced additional hurdles, such as bias in marriage prospects and workplace discrimination.
“This is not just a dermatological problem but a social emergency,” said Dr. Kapoor. Even among educated urban families, vitiligo remains widely misunderstood, leading to exclusion in social, religious, and professional settings.
While vitiligo is medically benign, its emotional consequences are profound. The study also explored new treatments like Janus Kinase (JAK) inhibitors combined with phototherapy, which showed promising improvements in skin pigmentation for some patients.
However, Dr. Kapoor warned that without addressing social stigma and providing psychological support, medical advances alone will not suffice.
With an estimated 70 million people worldwide living with vitiligo, public education and comprehensive care are crucial. “The real scars many patients carry are invisible,” Dr. Kapoor concluded. “We must pair medical treatment with mental health support and fight stigma at every level.”
Related topics:
